showed a trendp = 0.089
Results: Younger age and higher disease severity showed a trend toward reduced microbial diversity (β = 0.066, p = 0.089, and β = −0.054, p = 0.089).
Results: Younger age and higher disease severity showed a trend toward reduced microbial diversity (β = 0.066, p = 0.089, and β = −0.054, p = 0.089).
Although butyric acid is a well-established immunomodulatory metabolite essential for maintaining mucosal barrier integrity and immune tolerance [ 23 ], its direct association with PICU LOS did not reach statistical significance in this pilot cohort.